Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis

Brain

Volumn 138, Issue 9, 2015, Pages 2485-2492

  Mescam Mancini, Lénaig ^a   Allenbach, Yves ^b,c   Hervier, Baptiste ^b,d   Devilliers, Hervé ^e   Mariampillay, Kuberaka ^b   Dubourg, Odile ^f   Maisonobe, Thierry ^f   Gherardi, Romain ^g   Mezin, Paulette ^a   Preusse, Corinna ^c   Stenzel, Werner ^c   Benveniste, Olivier ^b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d INSERM   (France)

^e Hôpital de Dijon   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

anti synthetase; dermatomyositis; idiopathic inflammatory myopathies; necrotizing myopathies; polymyositis

Indexed keywords

CREATINE KINASE; JO 1 ANTIBODY; SIGNAL RECOGNITION PARTICLE; UTROPHIN; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; JO-1 ANTIBODY; LIGASE;

ADULT; ARTICLE; B LYMPHOCYTE; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; ELECTRON MICROSCOPY; ENDOMYSIUM; ENDOTHELIUM CELL; FEMALE; HISTOCOMPATIBILITY COMPLEX; HUMAN; HUMAN TISSUE; INCLUSION BODY MYOSITIS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYALGIA; MYOSITIS; NECROTIZING PERIFASCICULAR MYOSITIS; PERIMYSIUM; PHENOTYPE; POLYMYOSITIS; PRIORITY JOURNAL; T LYMPHOCYTE; BLOOD; IMMUNOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; RETROSPECTIVE STUDY; SKELETAL MUSCLE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; DERMATOMYOSITIS; FEMALE; HUMANS; LIGASES; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS; MYOSITIS, INCLUSION BODY; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 84940743653     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv192     Document Type: Article

References (23)

1. Allenbach Y, Tourte M, Stenzel W, Goebel H-H, Maisonobe T, Frances C, et al. Expanding the spectrum of livedoid vasculopathy: Peculiar neuromuscular manifestations. Neuropathol Appl Neurobiol 2015. Advance Access published on April 14, 2015, doi: 10. 1111/nan. 12243.
2. András C, Ponyi A, Constantin T, Csiki Z, Szekanecz E, Szodoray P, et al. Dermatomyositis and polymyositis associated with malignancy: A 21-year retrospective study. J Rheumatol 2008; 35: 438-444.
3. Aouizerate J, De Antonio M, Bassez G, Gherardi RK, Berenbaum F, Guillevin L, et al. Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy. Acta Neuropathol Commun 2014; 2: 154.
4. Benveniste O, Hilton-Jones D. International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009. Neuromuscul Disord 2010; 20: 414-21.
5. Betteridge Z, Gunawardena H, North J, Slinn J, McHugh N. Antisynthetase syndrome: A new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia. Rheumatol Oxf Engl 2007; 46: 1005-8.
6. Brouwer R, Hengstman GJ, Vree Egberts W, Ehrfeld H, Bozic B, Ghirardello A, et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001; 60: 116-23.
7. Chinoy H, Fertig N, Oddis CV, Ollier WE, Cooper RG. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis 2007; 66: 1345-9.
8. Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum 2010; 62: 2757-66.
9. Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest 2010; 138: 1464-74.
10. Estruch R, Grau JM, Fernández-SoláJ, Casademont J, Monforte R, Urbano-Márquez A. Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy. Hum Pathol 1992; 23: 888-95.
11. Hamaguchi Y, Kuwana M, Hoshino K, Hasegawa M, Kaji K, Matsushita T, et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: A multicenter cross-sectional study. Arch Dermatol 2011; 147: 391.
12. Hervier B, Devilliers H, Stanciu R, Meyer A, Uzunhan Y, Masseau A, et al. Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev 2012; 12: 210-17.
13. Hirakata M. Autoantibodies to aminoacyl-tRNA synthetases. Intern Med Tokyo Jpn 2005; 44: 527-8.
14. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004; 14: 337-45.
15. Koenig M, Fritzler MJ, Targoff IN, Troyanov Y, Senécal JL. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther 2007; 9: R78.
16. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Med Baltim 1991; 70: 360-74.
17. Mozaffar T, Pestronk A. Myopathy with anti-Jo-1 antibodies: Pathology in perimysium and neighbouring muscle fibres. J Neurol Neurosurg Psychiatry 2000; 68: 472-8.
18. Pestronk A. Acquired immune and inflammatory myopathies: Pathologic classification. Curr Opin Rheumatol 2011; 23: 595-604.
19. Preusse C, Goebel HH, Held J, Wengert O, Scheibe F, Irlbacher K, et al. Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile. Am J Pathol 2012; 181: 2161-71.
20. Stanciu R, Guiguet M, Musset L, Touitou D, Beigelman C, Rigolet A, et al. Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: Pulmonary involvement predicts disease-modifying antirheumatic drug use. J Rheumatol 2012; 39: 1835-9.
21. Stenzel W, Goebel HH, Aronica E. Review: immune-mediated necrotizing myopathies-a heterogeneous group of diseases with specific myopathological features. Neuropathol Appl Neurobiol 2012; 38: 632-46.
22. Targoff IN. Idiopathic inflammatory myopathy: Autoantibody update. Curr Rheumatol Rep 2002; 4: 434-41.
23. Wedderburn LR, Varsani H, Li CKC, Newton KR, Amato AA, Banwell B, et al. International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: A tool for potential use in clinical trials. Arthritis Rheum 2007; 57: 1192-201.